Results 81 to 90 of about 3,138,708 (171)

Near Infrared Photoimmunotherapy in the Treatment of Disseminated Peritoneal Ovarian Cancer [PDF]

open access: yesMolecular Cancer Therapeutics, 2015
Abstract Near infrared photoimmunotherapy (NIR-PIT) is a new cancer treatment that combines the specificity of intravenously injected antibodies for targeting tumors with the toxicity induced by photosensitizers after exposure to near infrared (NIR) light.
Kazuhide, Sato   +5 more
openaire   +2 more sources

Targeted Photo‐Induced Elimination of Tumor‐Associated Macrophages Suppresses Cancer Progression in a Murine Model

open access: yesCancer Science, Volume 117, Issue 11, Page 3121-3131, November 2026.
This study demonstrates the selective depletion of tumor‐associated macrophages (TAMs) by targeting CSF1R through near‐infrared photoimmunotherapy (NIR‐PIT). Using a combination of anti‐CSF1R Fab‐IR700 conjugates and localized light irradiation, we achieved tumor suppression and durable antitumor immunity without systemic toxicity.
Kohei Nakajima   +6 more
wiley   +1 more source

Near-Infrared Photoimmunotherapy Using a Small Protein Mimetic for HER2-Overexpressing Breast Cancer

open access: yes, 2019
Near-infrared photoimmunotherapy (NIR-PIT) is a new and promising cancer therapy based on a monoclonal antibody conjugated to a photosensitizer which is activated by near-infrared light irradiation, causing cell death.
Takamasa Suzuki   +7 more
core   +1 more source

Evaluation of a Novel Lateral Emitting Laser Fiber for Near-Infrared Photoimmunotherapy. [PDF]

open access: yesCancers (Basel)
Near-infrared photoimmunotherapy (NIR-PIT) is a new cancer therapy that uses NIR light and conjugates of a tumor-targeting monoclonal antibody and phthalocyanine dye.
Suzuki M, Kobayashi H, Hanaoka H.
europepmc   +2 more sources

Near-infrared photoimmunotherapy: a comparison of light dosing schedules

open access: yesOncotarget, 2017
Near infrared photoimmunotherapy (NIR-PIT) is a newly-developed cancer therapy in which a monoclonal antibody is conjugated to a near-infrared photoabsorber, IR700 to form an antibody photoabsorber conjugate (APC). After the APC binds to cancer cells expressing the cognate antigen, exposure to NIR light results in rapid, highly selective necrotic cell ...
Ogata, Fusa   +7 more
openaire   +3 more sources

Supramolecular Degraders: An Emerging Paradigm in Targeted Protein Degradation

open access: yesAdvanced Science, Volume 13, Issue 58, 19 October 2026.
Dynamic supramolecular assembly reshapes targeted protein degradation by coordinating modular degrader construction, delivery, functional integration, and intracellular assembly or activation across proteasomal, endosomal–lysosomal, and autophagy–lysosomal pathways.
Kongjun Liu   +8 more
wiley   +1 more source

Phototherapy Strategies for Cancer Treatment: Mechanisms and Emerging Nanomaterials

open access: yesAggregate, Volume 7, Issue 10, October 2026.
Phototherapy offers spatiotemporally controlled cancer treatment by converting light into heat, reactive oxygen species, immune activation, and therapeutic gas release. This review summarizes the mechanisms and emerging nanomaterials for photothermal therapy, photodynamic therapy, photoimmunotherapy, and photo‐gas therapy, emphasizing structure ...
Fan Liu, Jun Huang
wiley   +1 more source

Nanomedicine applications in lymphoma: Advancing precision diagnostics, targeted therapeutics, and prospective developments

open access: yesVIEW, Volume 7, Issue 5, October 2026.
Lymphoma is a group of blood cancers that can appear in lymph nodes, blood, bone marrow, spleen, liver, or the central nervous system, which makes drug delivery and disease monitoring difficult. This review summarizes how nanomedicine technologies may improve targeted treatment and imaging, while carefully separating approved or guideline‐supported ...
Mohd Ahmar Rauf   +5 more
wiley   +1 more source

Achieving Hierarchical Selective Ablation and Remodeling “Cold” Tumors via a Dual‐Organelle‐Targeted AIE Nanoplatform: Synergizing Ferroptosis, ICD, and cGAS–STING Activation

open access: yesAggregate, Volume 7, Issue 9, September 2026.
A folate receptor‐targeted nanoplatform co‐targets lipid droplets and lysosomes to orchestrate ferroptosis, ICD, and STING activation for photo‐immunotherapy. Under light, it induces ferroptosis and ICD, releasing mtDNA that synergizes with a co‐delivered agonist to hyperactivate the STING pathway and remodel the tumor microenvironment.
Wenkai Zhang   +6 more
wiley   +1 more source

Near-Infrared Photoimmunotherapy: Photoactivatable Antibody–Drug Conjugates (ADCs)

open access: yesBioconjugate Chemistry, 2019
Cancer treatment has been founded traditionally on the three approaches of surgery, radiation, and chemotherapy with the latter recognized as the obvious systemic treatment approach applicable to disease that has spread. Although significant progress has been made over nearly 100 years of developing systemic treatments, it remains clear that use of the
Hisataka Kobayashi   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy